18 June 2013
Keywords: tykerb, side, effects, manageable, study, article, july
Article | 13 August 2007
An article in the July issue of The Oncologist suggests that adverse reactions associated with UK drug major GlaxoSmithKline's Tykerb
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
13 August 2007
© 2013 thepharmaletter.com